Nusa Raya Cipta Tbk PT
IDX:NRCA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nusa Raya Cipta Tbk PT
IDX:NRCA
|
ID |
|
Elicio Therapeutics Inc
NASDAQ:ELTX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NRCA's stock price target?
Not Available
NRCA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nusa Raya Cipta Tbk PT?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 1 year is 10%.
What is the Operating Income forecast for Nusa Raya Cipta Tbk PT?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 1 year is 6%.
What is the Net Income forecast for Nusa Raya Cipta Tbk PT?
Projected CAGR
-17%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 1 year is -17%.
